Suchergebnisse - "Ye, Hongmei"

PubPharm (15)

1

Role and molecular mechanisms of SGLT2 inhibitors in pathological cardiac remodeling (Review)

enthalten in: Molecular medicine reports | 2024

von Chen, B. | Guo, J. | Ye, H. | +2

2

Segmentation of intravascular ultrasound images based on convex–concave adjustment in extreme regions

enthalten in: The visual computer | 2022

von Wang, Y. | Sun, J. | Gao, X. | +1

3

INFORMATION VERIFICATION METHOD AND DEVICE

enthalten in: Europäisches Patentamt | 2020

von YE HONGMEI | WANG YUN

4

Information checking method and device

enthalten in: Europäisches Patentamt | 2020

von YE HONGMEI | WANG YUN

5

Medical administration information management system, terminal and storage medium

enthalten in: Europäisches Patentamt | 2020

von HOU LENGCHEN | YANG JIAFANG | XIA HONGBIN | +6

6

TUMOR SIZE IS AN INDEPENDENT PREDICTOR OF MORTALITY RISK IN DIFFERENTIATED THYROID CANCER PATIENTS WITH T4 DISEASE

enthalten in: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists | 2020

von Wang, Z. | Zhang, Q. | Ye, H. | +4

7

Medicine for treating goiter

enthalten in: Europäisches Patentamt | 2015

von WANG XILONG | QIU WENXIU | YE HONGMEI | +3

8

Nebivolol induces distinct changes in profibrosis microRNA expression compared with atenolol, in salt-sensitive hypertensive rats

enthalten in: Hypertension (Dallas, Tex. : 1979) | 2013

von Ye, H. | Ling, S. | Castillo, A. | +7

9

Nebivolol Induces Distinct Changes in Profibrosis MicroRNA Expression Compared With Atenolol, in Salt-Sensitive Hypertensive Rats

enthalten in: Hypertension | 2013

von Ye, H. | Ling, S. | Castillo, A. | +7

10

Phosphodiesterase-3 inhibition augments the myocardial infarct size-limiting effects of exenatide in mice with type 2 diabetes

enthalten in: American journal of physiology. Heart and circulatory physiology | 2013

von Ye, Y. | Qian, J. | Castillo, A. | +5